| A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis S Buch, F Stickel, E Trépo, M Way, A Herrmann, HD Nischalke, M Brosch, ... Nature genetics 47 (12), 1443-1448, 2015 | 605 | 2015 |
| The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus P Amodio, C Bemeur, R Butterworth, J Cordoba, A Kato, S Montagnese, ... Hepatology 58 (1), 325-336, 2013 | 543 | 2013 |
| The efficacy of acamprosate in the maintenance of abstinence in alcohol‐dependent individuals: results of a meta‐analysis K Mann, P Lehert, MY Morgan Alcoholism: Clinical and Experimental Research 28 (1), 51-63, 2004 | 516 | 2004 |
| the design of clinical trials in hepatic encephalopathy–an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement JS Bajaj, J Cordoba, KD Mullen, P Amodio, DL Shawcross, ... Alimentary pharmacology & therapeutics 33 (7), 739-747, 2011 | 440 | 2011 |
| A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse J Chick, R Anton, K Checinski, R Croop, DC Drummond, R Farmer, ... Alcohol and alcoholism 35 (6), 587-593, 2000 | 407 | 2000 |
| Characteristics of minimal hepatic encephalopathy P Amodio, S Montagnese, A Gatta, MY Morgan Metabolic brain disease 19, 253-267, 2004 | 375 | 2004 |
| Sex-related differences among 100 patients with alcoholic liver disease. MY Morgan, S Sherlock Br Med J 1 (6066), 939-941, 1977 | 349 | 1977 |
| Malnutrition and sarcopenia predict post‐liver transplantation outcomes independently of the Model for End‐stage Liver Disease score M Kalafateli, K Mantzoukis, Y Choi Yau, AO Mohammad, S Arora, ... Journal of cachexia, sarcopenia and muscle 8 (1), 113-121, 2017 | 339 | 2017 |
| Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits H Zhou, JM Sealock, S Sanchez-Roige, TK Clarke, DF Levey, Z Cheng, ... Nature neuroscience 23 (7), 809-818, 2020 | 326 | 2020 |
| Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis RW Chapman, MY Morgan, M Laulicht, AV Hoffbrand, S Sherlock Digestive diseases and sciences 27, 909-916, 1982 | 296 | 1982 |
| Ethanol elimination in males and females: relationship to menstrual cycle and body composition AW Marshall, D Kingstone, M Boss, MY Morgan Hepatology 3 (5), 701-706, 1983 | 282 | 1983 |
| Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease. MY Morgan, JP Milsom, S Sherlock Gut 19 (11), 1068-1073, 1978 | 279 | 1978 |
| Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis MY Morgan, AM Madden, CT Soulsby, RW Morris Hepatology 44 (4), 823-835, 2006 | 269 | 2006 |
| United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol J Chick, H Howlett, MY Morgan, B Ritson Alcohol and Alcoholism 35 (2), 176-187, 2000 | 265 | 2000 |
| Plasma amino-acid patterns in liver disease. MY Morgan, AW Marshall, JP Milsom, S Sherlock Gut 23 (5), 362-370, 1982 | 241 | 1982 |
| Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis LL Gluud, H Vilstrup, MY Morgan Cochrane Database of Systematic Reviews, 2016 | 209 | 2016 |
| Impaired oxidation of debrisoquine in patients with perhexiline liver injury. MY Morgan, R Reshef, RR Shah, NS Oates, RL Smith, S Sherlock Gut 25 (10), 1057-1064, 1984 | 203 | 1984 |
| Alcohol and nutrition. MY Morgan | 194 | 1982 |
| Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis J Argemi, MU Latasa, SR Atkinson, IO Blokhin, V Massey, JP Gue, ... Nature communications 10 (1), 3126, 2019 | 186 | 2019 |
| Evaluation of the efficacy and safety of rifaximin in the treatment of hepatic encephalopathy: a double-blind, randomized, dose-finding multi-centre study R Williams, OFW James, TW Warnes, MY Morgan European journal of gastroenterology & hepatology 12 (2), 203-208, 2000 | 182 | 2000 |
